New Delhi: Acting tough on the unilateral carbon tax proposed by the European Union for airlines operating to and from the region, India has barred its airlines from submitting any emission data to

India has told the US that it does not intend to alter the domestic content requirement in its ambitious national solar power generation programme as it is essentially procurement by the government

Even as the Obama administration works overtime to wind down two wars, in Iraq and Afghanistan, it could well be on the brink of opening up a new battle front — an economic slugfest with China.

This week the U.S. Commerce Department announced, after months of hand-wringing and suspense, that it would be imposing tariffs on solar panels made in China, after investigations supposedly revealed that Chinese manufacturers were receiving significant amounts of ‘ illegal' subsidies for the clean-tech product.

The United States, Japan and European Union plan to bring a new trade case against China over its export restrictions on rare earth minerals used in a variety of high-tech and clean energy products

The government today asserted India would invoke the flexibility it had under the WTO agreement on Trade Related Intellectual Property Rights (TRIPs) for compulsory licensing of patented drugs to e

Cancer-treatment drug Nexavar will soon be available at Rs. 8,880 per pack of 120 tablets. Bayer, a German multi-national, holds the patent for Nexavar (the brand name of sorafenib tosylate), which now sells at Rs.2.84 lakh.

The way for such a huge reduction in the price is cleared with India invoking a World Trade Organisation (WTO) provision and permitting the Hyderabad-based Natco Pharma to make sorafenib tosylate, which is used to treat kidney and liver cancer.